FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

39332211000001106: Pertuzumab 600mg/10ml / Trastuzumab 600mg/10ml solution for injection vials (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Feb 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
70591000001114 Pertuzumab 600mg/10ml / Trastuzumab 600mg/10ml solution for injection vials en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
70601000001117 Pertuzumab 600mg/10ml / Trastuzumab 600mg/10ml solution for injection vials (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Pertuzumab 600mg/10ml / Trastuzumab 600mg/10ml solution for injection vials Has dispensed dose form Conventional release solution for injection true Inferred relationship Existential restriction modifier
Pertuzumab 600mg/10ml / Trastuzumab 600mg/10ml solution for injection vials VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Pertuzumab 600mg/10ml / Trastuzumab 600mg/10ml solution for injection vials Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Subcutaneous route true Inferred relationship Existential restriction modifier
Pertuzumab 600mg/10ml / Trastuzumab 600mg/10ml solution for injection vials Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route solutioninjection.subcutaneous ontology form and route true Inferred relationship Existential restriction modifier
Pertuzumab 600mg/10ml / Trastuzumab 600mg/10ml solution for injection vials Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Pertuzumab 600mg/10ml / Trastuzumab 600mg/10ml solution for injection vials Has specific active ingredient Trastuzumab true Inferred relationship Existential restriction modifier
Pertuzumab 600mg/10ml / Trastuzumab 600mg/10ml solution for injection vials VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Pertuzumab 600mg/10ml / Trastuzumab 600mg/10ml solution for injection vials Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Pertuzumab 600mg/10ml / Trastuzumab 600mg/10ml solution for injection vials Has specific active ingredient Pertuzumab true Inferred relationship Existential restriction modifier
Pertuzumab 600mg/10ml / Trastuzumab 600mg/10ml solution for injection vials Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Pertuzumab 600mg/10ml / Trastuzumab 600mg/10ml solution for injection vials Is a Pertuzumab + Trastuzumab true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Phesgo 600mg/600mg/10ml solution for injection vials (Roche Products Ltd) Is a True Pertuzumab 600mg/10ml / Trastuzumab 600mg/10ml solution for injection vials Inferred relationship Existential restriction modifier
Pertuzumab 600mg/10ml / Trastuzumab 600mg/10ml solution for injection vials 1 vial Has VMP True Pertuzumab 600mg/10ml / Trastuzumab 600mg/10ml solution for injection vials Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start